Loading…

Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic

Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia. Only 21 IBA57 mutations have been reported, therefore the phenotypic spectrum of IBA57-related mitochondrial disease ha...

Full description

Saved in:
Bibliographic Details
Published in:Journal of human genetics 2018-12, Vol.63 (12), p.1223-1229
Main Authors: Hamanaka, Kohei, Miyatake, Satoko, Zerem, Ayelet, Lev, Dorit, Blumkin, Luba, Yokochi, Kenji, Fujita, Atsushi, Imagawa, Eri, Iwama, Kazuhiro, Nakashima, Mitsuko, Mitsuhashi, Satomi, Mizuguchi, Takeshi, Takata, Atsushi, Miyake, Noriko, Saitsu, Hirotomo, van der Knaap, Marjo S, Lerman-Sagie, Tally, Matsumoto, Naomichi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3
cites cdi_FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3
container_end_page 1229
container_issue 12
container_start_page 1223
container_title Journal of human genetics
container_volume 63
creator Hamanaka, Kohei
Miyatake, Satoko
Zerem, Ayelet
Lev, Dorit
Blumkin, Luba
Yokochi, Kenji
Fujita, Atsushi
Imagawa, Eri
Iwama, Kazuhiro
Nakashima, Mitsuko
Mitsuhashi, Satomi
Mizuguchi, Takeshi
Takata, Atsushi
Miyake, Noriko
Saitsu, Hirotomo
van der Knaap, Marjo S
Lerman-Sagie, Tally
Matsumoto, Naomichi
description Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia. Only 21 IBA57 mutations have been reported, therefore the phenotypic spectrum of IBA57-related mitochondrial disease has not yet been fully elucidated. In this study, we performed whole-exome sequencing on a Sepharadi Jewish and Japanese family with leukodystrophy. We identified four novel biallelic variants in IBA57 in the two families: one frameshift insertion and three missense variants. The three missense variants were predicted to be disease-causing by multiple in silico tools. The 29-year-old Sepharadi Jewish male had infantile-onset optic atrophy with clinically asymptomatic leukodystrophy involving periventricular white matter. The 19-year-old younger brother, with the same compound heterozygous IBA57 variants, had a similar clinical course until 7 years of age. However, he then developed a rapidly progressive spastic paraparesis following a febrile illness. A 7-year-old Japanese girl had developmental regression, spastic quadriplegia, and abnormal periventricular white matter signal on brain magnetic resonance imaging performed at 8 months of age. She had febrile convulsions at the age of 18 months and later developed epilepsy. In summary, we have identified four novel IBA57 mutations in two unrelated families. Consequently, we describe a patient with infantile-onset optic atrophy and asymptomatic white matter involvement, thus broadening the phenotypic spectrum of biallelic IBA57 mutations.
doi_str_mv 10.1038/s10038-018-0516-x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2113283381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2137454902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3</originalsourceid><addsrcrecordid>eNpdkEFLwzAUx4Mobk4_gBcJePFSTV4a23ibY-pg4EVBvIS0TV1n29QkhfXbm7npwcPjPXi__-PxQ-ickmtKWHrjKAktIjQUp7fR5gCNacx4BAzeDn_mOAoLOkInzq1JoCGBYzRiBHgKJBmj9_mmU21RtR_YrzTuVro1fug0NiVe3E95gpveK1-Z1t1hq2vldYFr3X-aYnDemm414Fy1YdWoqsXKDU3nTRMS-Sk6KlXt9Nm-T9Drw_xl9hQtnx8Xs-kyymMqfAQCsiJNSio4pJCVrCgJ5aAyIohKk1jwpEiVDpiIeQEgGBdcs1A8h7zUbIKudnc7a7567bxsKpfrulatNr2TQCmDlLGUBvTyH7o2vW3Dd4FiScxjQSBQdEfl1jhndSk7WzXKDpISuRUvd-JlEC-34uUmZC72l_us0cVf4tc0-wZ36X2s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2137454902</pqid></control><display><type>article</type><title>Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic</title><source>Springer Link</source><creator>Hamanaka, Kohei ; Miyatake, Satoko ; Zerem, Ayelet ; Lev, Dorit ; Blumkin, Luba ; Yokochi, Kenji ; Fujita, Atsushi ; Imagawa, Eri ; Iwama, Kazuhiro ; Nakashima, Mitsuko ; Mitsuhashi, Satomi ; Mizuguchi, Takeshi ; Takata, Atsushi ; Miyake, Noriko ; Saitsu, Hirotomo ; van der Knaap, Marjo S ; Lerman-Sagie, Tally ; Matsumoto, Naomichi</creator><creatorcontrib>Hamanaka, Kohei ; Miyatake, Satoko ; Zerem, Ayelet ; Lev, Dorit ; Blumkin, Luba ; Yokochi, Kenji ; Fujita, Atsushi ; Imagawa, Eri ; Iwama, Kazuhiro ; Nakashima, Mitsuko ; Mitsuhashi, Satomi ; Mizuguchi, Takeshi ; Takata, Atsushi ; Miyake, Noriko ; Saitsu, Hirotomo ; van der Knaap, Marjo S ; Lerman-Sagie, Tally ; Matsumoto, Naomichi</creatorcontrib><description>Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia. Only 21 IBA57 mutations have been reported, therefore the phenotypic spectrum of IBA57-related mitochondrial disease has not yet been fully elucidated. In this study, we performed whole-exome sequencing on a Sepharadi Jewish and Japanese family with leukodystrophy. We identified four novel biallelic variants in IBA57 in the two families: one frameshift insertion and three missense variants. The three missense variants were predicted to be disease-causing by multiple in silico tools. The 29-year-old Sepharadi Jewish male had infantile-onset optic atrophy with clinically asymptomatic leukodystrophy involving periventricular white matter. The 19-year-old younger brother, with the same compound heterozygous IBA57 variants, had a similar clinical course until 7 years of age. However, he then developed a rapidly progressive spastic paraparesis following a febrile illness. A 7-year-old Japanese girl had developmental regression, spastic quadriplegia, and abnormal periventricular white matter signal on brain magnetic resonance imaging performed at 8 months of age. She had febrile convulsions at the age of 18 months and later developed epilepsy. In summary, we have identified four novel IBA57 mutations in two unrelated families. Consequently, we describe a patient with infantile-onset optic atrophy and asymptomatic white matter involvement, thus broadening the phenotypic spectrum of biallelic IBA57 mutations.</description><identifier>ISSN: 1434-5161</identifier><identifier>EISSN: 1435-232X</identifier><identifier>DOI: 10.1038/s10038-018-0516-x</identifier><identifier>PMID: 30258207</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Adult ; Age ; Atrophy ; Carrier Proteins - genetics ; Convulsions ; Epilepsy ; Female ; Fever ; Hereditary Central Nervous System Demyelinating Diseases - diagnostic imaging ; Hereditary Central Nervous System Demyelinating Diseases - genetics ; Humans ; Intellectual disabilities ; Leukodystrophy ; Magnetic resonance imaging ; Male ; Mitochondria ; Mutation ; Neuroimaging ; Optic atrophy ; Phenotype ; Phenotypes ; Spastic paraparesis ; Spastic paraplegia ; Substantia alba</subject><ispartof>Journal of human genetics, 2018-12, Vol.63 (12), p.1223-1229</ispartof><rights>Copyright Nature Publishing Group Dec 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3</citedby><cites>FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3</cites><orcidid>0000-0002-2584-9524 ; 0000-0003-0723-0960</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30258207$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hamanaka, Kohei</creatorcontrib><creatorcontrib>Miyatake, Satoko</creatorcontrib><creatorcontrib>Zerem, Ayelet</creatorcontrib><creatorcontrib>Lev, Dorit</creatorcontrib><creatorcontrib>Blumkin, Luba</creatorcontrib><creatorcontrib>Yokochi, Kenji</creatorcontrib><creatorcontrib>Fujita, Atsushi</creatorcontrib><creatorcontrib>Imagawa, Eri</creatorcontrib><creatorcontrib>Iwama, Kazuhiro</creatorcontrib><creatorcontrib>Nakashima, Mitsuko</creatorcontrib><creatorcontrib>Mitsuhashi, Satomi</creatorcontrib><creatorcontrib>Mizuguchi, Takeshi</creatorcontrib><creatorcontrib>Takata, Atsushi</creatorcontrib><creatorcontrib>Miyake, Noriko</creatorcontrib><creatorcontrib>Saitsu, Hirotomo</creatorcontrib><creatorcontrib>van der Knaap, Marjo S</creatorcontrib><creatorcontrib>Lerman-Sagie, Tally</creatorcontrib><creatorcontrib>Matsumoto, Naomichi</creatorcontrib><title>Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic</title><title>Journal of human genetics</title><addtitle>J Hum Genet</addtitle><description>Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia. Only 21 IBA57 mutations have been reported, therefore the phenotypic spectrum of IBA57-related mitochondrial disease has not yet been fully elucidated. In this study, we performed whole-exome sequencing on a Sepharadi Jewish and Japanese family with leukodystrophy. We identified four novel biallelic variants in IBA57 in the two families: one frameshift insertion and three missense variants. The three missense variants were predicted to be disease-causing by multiple in silico tools. The 29-year-old Sepharadi Jewish male had infantile-onset optic atrophy with clinically asymptomatic leukodystrophy involving periventricular white matter. The 19-year-old younger brother, with the same compound heterozygous IBA57 variants, had a similar clinical course until 7 years of age. However, he then developed a rapidly progressive spastic paraparesis following a febrile illness. A 7-year-old Japanese girl had developmental regression, spastic quadriplegia, and abnormal periventricular white matter signal on brain magnetic resonance imaging performed at 8 months of age. She had febrile convulsions at the age of 18 months and later developed epilepsy. In summary, we have identified four novel IBA57 mutations in two unrelated families. Consequently, we describe a patient with infantile-onset optic atrophy and asymptomatic white matter involvement, thus broadening the phenotypic spectrum of biallelic IBA57 mutations.</description><subject>Adult</subject><subject>Age</subject><subject>Atrophy</subject><subject>Carrier Proteins - genetics</subject><subject>Convulsions</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Fever</subject><subject>Hereditary Central Nervous System Demyelinating Diseases - diagnostic imaging</subject><subject>Hereditary Central Nervous System Demyelinating Diseases - genetics</subject><subject>Humans</subject><subject>Intellectual disabilities</subject><subject>Leukodystrophy</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Mitochondria</subject><subject>Mutation</subject><subject>Neuroimaging</subject><subject>Optic atrophy</subject><subject>Phenotype</subject><subject>Phenotypes</subject><subject>Spastic paraparesis</subject><subject>Spastic paraplegia</subject><subject>Substantia alba</subject><issn>1434-5161</issn><issn>1435-232X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpdkEFLwzAUx4Mobk4_gBcJePFSTV4a23ibY-pg4EVBvIS0TV1n29QkhfXbm7npwcPjPXi__-PxQ-ickmtKWHrjKAktIjQUp7fR5gCNacx4BAzeDn_mOAoLOkInzq1JoCGBYzRiBHgKJBmj9_mmU21RtR_YrzTuVro1fug0NiVe3E95gpveK1-Z1t1hq2vldYFr3X-aYnDemm414Fy1YdWoqsXKDU3nTRMS-Sk6KlXt9Nm-T9Drw_xl9hQtnx8Xs-kyymMqfAQCsiJNSio4pJCVrCgJ5aAyIohKk1jwpEiVDpiIeQEgGBdcs1A8h7zUbIKudnc7a7567bxsKpfrulatNr2TQCmDlLGUBvTyH7o2vW3Dd4FiScxjQSBQdEfl1jhndSk7WzXKDpISuRUvd-JlEC-34uUmZC72l_us0cVf4tc0-wZ36X2s</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Hamanaka, Kohei</creator><creator>Miyatake, Satoko</creator><creator>Zerem, Ayelet</creator><creator>Lev, Dorit</creator><creator>Blumkin, Luba</creator><creator>Yokochi, Kenji</creator><creator>Fujita, Atsushi</creator><creator>Imagawa, Eri</creator><creator>Iwama, Kazuhiro</creator><creator>Nakashima, Mitsuko</creator><creator>Mitsuhashi, Satomi</creator><creator>Mizuguchi, Takeshi</creator><creator>Takata, Atsushi</creator><creator>Miyake, Noriko</creator><creator>Saitsu, Hirotomo</creator><creator>van der Knaap, Marjo S</creator><creator>Lerman-Sagie, Tally</creator><creator>Matsumoto, Naomichi</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2584-9524</orcidid><orcidid>https://orcid.org/0000-0003-0723-0960</orcidid></search><sort><creationdate>20181201</creationdate><title>Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic</title><author>Hamanaka, Kohei ; Miyatake, Satoko ; Zerem, Ayelet ; Lev, Dorit ; Blumkin, Luba ; Yokochi, Kenji ; Fujita, Atsushi ; Imagawa, Eri ; Iwama, Kazuhiro ; Nakashima, Mitsuko ; Mitsuhashi, Satomi ; Mizuguchi, Takeshi ; Takata, Atsushi ; Miyake, Noriko ; Saitsu, Hirotomo ; van der Knaap, Marjo S ; Lerman-Sagie, Tally ; Matsumoto, Naomichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Age</topic><topic>Atrophy</topic><topic>Carrier Proteins - genetics</topic><topic>Convulsions</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Fever</topic><topic>Hereditary Central Nervous System Demyelinating Diseases - diagnostic imaging</topic><topic>Hereditary Central Nervous System Demyelinating Diseases - genetics</topic><topic>Humans</topic><topic>Intellectual disabilities</topic><topic>Leukodystrophy</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Mitochondria</topic><topic>Mutation</topic><topic>Neuroimaging</topic><topic>Optic atrophy</topic><topic>Phenotype</topic><topic>Phenotypes</topic><topic>Spastic paraparesis</topic><topic>Spastic paraplegia</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hamanaka, Kohei</creatorcontrib><creatorcontrib>Miyatake, Satoko</creatorcontrib><creatorcontrib>Zerem, Ayelet</creatorcontrib><creatorcontrib>Lev, Dorit</creatorcontrib><creatorcontrib>Blumkin, Luba</creatorcontrib><creatorcontrib>Yokochi, Kenji</creatorcontrib><creatorcontrib>Fujita, Atsushi</creatorcontrib><creatorcontrib>Imagawa, Eri</creatorcontrib><creatorcontrib>Iwama, Kazuhiro</creatorcontrib><creatorcontrib>Nakashima, Mitsuko</creatorcontrib><creatorcontrib>Mitsuhashi, Satomi</creatorcontrib><creatorcontrib>Mizuguchi, Takeshi</creatorcontrib><creatorcontrib>Takata, Atsushi</creatorcontrib><creatorcontrib>Miyake, Noriko</creatorcontrib><creatorcontrib>Saitsu, Hirotomo</creatorcontrib><creatorcontrib>van der Knaap, Marjo S</creatorcontrib><creatorcontrib>Lerman-Sagie, Tally</creatorcontrib><creatorcontrib>Matsumoto, Naomichi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hamanaka, Kohei</au><au>Miyatake, Satoko</au><au>Zerem, Ayelet</au><au>Lev, Dorit</au><au>Blumkin, Luba</au><au>Yokochi, Kenji</au><au>Fujita, Atsushi</au><au>Imagawa, Eri</au><au>Iwama, Kazuhiro</au><au>Nakashima, Mitsuko</au><au>Mitsuhashi, Satomi</au><au>Mizuguchi, Takeshi</au><au>Takata, Atsushi</au><au>Miyake, Noriko</au><au>Saitsu, Hirotomo</au><au>van der Knaap, Marjo S</au><au>Lerman-Sagie, Tally</au><au>Matsumoto, Naomichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic</atitle><jtitle>Journal of human genetics</jtitle><addtitle>J Hum Genet</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>63</volume><issue>12</issue><spage>1223</spage><epage>1229</epage><pages>1223-1229</pages><issn>1434-5161</issn><eissn>1435-232X</eissn><abstract>Biallelic mutations in IBA57 cause a mitochondrial disorder with a broad phenotypic spectrum that ranges from severe intellectual disability to adolescent-onset spastic paraplegia. Only 21 IBA57 mutations have been reported, therefore the phenotypic spectrum of IBA57-related mitochondrial disease has not yet been fully elucidated. In this study, we performed whole-exome sequencing on a Sepharadi Jewish and Japanese family with leukodystrophy. We identified four novel biallelic variants in IBA57 in the two families: one frameshift insertion and three missense variants. The three missense variants were predicted to be disease-causing by multiple in silico tools. The 29-year-old Sepharadi Jewish male had infantile-onset optic atrophy with clinically asymptomatic leukodystrophy involving periventricular white matter. The 19-year-old younger brother, with the same compound heterozygous IBA57 variants, had a similar clinical course until 7 years of age. However, he then developed a rapidly progressive spastic paraparesis following a febrile illness. A 7-year-old Japanese girl had developmental regression, spastic quadriplegia, and abnormal periventricular white matter signal on brain magnetic resonance imaging performed at 8 months of age. She had febrile convulsions at the age of 18 months and later developed epilepsy. In summary, we have identified four novel IBA57 mutations in two unrelated families. Consequently, we describe a patient with infantile-onset optic atrophy and asymptomatic white matter involvement, thus broadening the phenotypic spectrum of biallelic IBA57 mutations.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>30258207</pmid><doi>10.1038/s10038-018-0516-x</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2584-9524</orcidid><orcidid>https://orcid.org/0000-0003-0723-0960</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1434-5161
ispartof Journal of human genetics, 2018-12, Vol.63 (12), p.1223-1229
issn 1434-5161
1435-232X
language eng
recordid cdi_proquest_miscellaneous_2113283381
source Springer Link
subjects Adult
Age
Atrophy
Carrier Proteins - genetics
Convulsions
Epilepsy
Female
Fever
Hereditary Central Nervous System Demyelinating Diseases - diagnostic imaging
Hereditary Central Nervous System Demyelinating Diseases - genetics
Humans
Intellectual disabilities
Leukodystrophy
Magnetic resonance imaging
Male
Mitochondria
Mutation
Neuroimaging
Optic atrophy
Phenotype
Phenotypes
Spastic paraparesis
Spastic paraplegia
Substantia alba
title Expanding the phenotype of IBA57 mutations: related leukodystrophy can remain asymptomatic
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A46%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expanding%20the%20phenotype%20of%20IBA57%20mutations:%20related%20leukodystrophy%20can%20remain%20asymptomatic&rft.jtitle=Journal%20of%20human%20genetics&rft.au=Hamanaka,%20Kohei&rft.date=2018-12-01&rft.volume=63&rft.issue=12&rft.spage=1223&rft.epage=1229&rft.pages=1223-1229&rft.issn=1434-5161&rft.eissn=1435-232X&rft_id=info:doi/10.1038/s10038-018-0516-x&rft_dat=%3Cproquest_cross%3E2137454902%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c419t-292bd87f195282bf3df0152ab090a874957d8ae292945d2293595e395e5c2cfe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2137454902&rft_id=info:pmid/30258207&rfr_iscdi=true